[1] Holick MF.Vitamin D deficiency[J].New England Journal of Medicine, 2007, 357(3):266-281. [2] Rodríguez-Rodríguez E, Aparicio A, López-Sobaler A, et al.Vitamin D status in a group of Spanish schoolchildren[J].Minerva Pediatrica, 2011, 63(1):11-18. [3] 张倩, 赵静, 张环美, 等.北京市郊区儿童维生素 D 营养状况与骨量的关系[J].中国预防医学杂志, 2010, 58(8):773-777. [4] Misra M, Pacaud D, Petryk A, et al.Vitamin D deficiency in children and its management:review of current knowledge and recommendations[J].Pediatrics, 2008, 122(2):398-417. [5] Alemzadeh R, Kichler J, Babar G, et al.Hypovitaminosis D in obese children and adolescents:relationship with adiposity, insulin sensitivity, ethnicity, and season[J].Metabolism, 2008, 57(2):183-191. [6] Baeke F, Takiishi T, Korf H, et al.Vitamin D:modulator of the immune system[J].Current Opinion in Pharmacology, 2010, 10(4):482-496. [7] Guillot X, Semerano L, Saidenberg-Kermanac'hN, et al.Vitamin D and inflammation[J].Joint Bone Spine, 2010, 77(6):552-557. [8] Xu H, Soruri A, Gieseler R, et al.1, 25-Dihydroxyvitamin D3 Exerts opposing effects to IL-4 on MHC class-II antigen expression, accessory activity, and phagocytosis of human monocytes[J].Scandinavian Journal of Immunology, 1993, 38(6):535-540. [9] Almerighi C, Sinistro A, Cavazza A, et al.1α, 25-dihydroxyvitamin D3 inhibits CD40L-induced pro-inflammatory and immunomodulatory activity in human monocytes[J].Cytokine, 2009, 45(3):190-197. [10] Sadeghi K, Wessner B, Laggner U, et al.Vitamin D3 down-regulates monocyte TLR expression and triggers hyporesponsiveness to pathogen-associated molecular patterns[J].European Journal of Immunology, 2006, 36(2):361-370. [11] Dickie LJ, Church LD, Coulthard LR, et al.Vitamin D3 down-regulates intracellular Toll-like receptor 9 expression and Toll-like receptor 9-induced IL-6 production in human monocytes[J].Rheumatology, 2010, 49(8):1466-1471. [12] Khoo A-L, Chai LY, Koenen HJ, et al.1, 25-dihydroxyvitamin D3 modulates cytokine production induced by Candida albicans:impact of seasonal variation of immune responses[J].Journal of Infectious Diseases, 2011, 203(1):122-130. [13] White JH.Vitamin D as an inducer of cathelicidin antimicrobial peptide expression:past, present and future[J].The Journal of Steroid Biochemistry and Molecular Biology, 2010, 121(1):234-238. [14] Back O, Blomquist HK, Hernell O, et al.Does vitamin D intake during infancy promote the development of atopic allergy?[J].Acta Dermato-venereologica, 2009, 89(1):28-32. [15] Hughes D, Norton R.Vitamin D and respiratory health[J].Clinical & Experimental Immunology, 2009, 158(1):20-25. [16] von Essen MR, Kongsbak M, Schjerling P, et al.Vitamin D controls T cell antigen receptor signaling and activation of human T cells[J].Nat Immunol, 2010, 11(4):344-349. [17] Jeffery LE, Burke F, Mura M, et al.1, 25-Dihydroxyvitamin D3 and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3[J].The Journal of Immunology, 2009, 183(9):5458-5467. [18] Khoo AL, Joosten I, Michels M, et al.1, 25-Dihydroxyvitamin D3 inhibits proliferation but not the suppressive function of regulatory T cells in the absence of antigen-presenting cells[J].Immunology, 2011, 134(4):459-468. [19] Chen S, Sims GP, Chen XX, et al.Modulatory efects of 1, 25-Dihydroxyvitamin D3 on Human B celldifferentiation[J].J Immunol, 2007, 179(3):1634 -1647. [20] Geldmeyer-Hilt K, Heine G, Hartmann B, et al.1, 25-dihydroxyvitamin D3 impairs NF-КB activation in human naive B cells[J].Biochem Biophys Res Commun, 2011, 407(4):699-702. [21] Scragg R, Camargo CA.Frequency of leisure-time physical activity and serum25-dihydroxyvitamin D levels in the US population:results from the Third National Health and Nutrition Examination Survey[J].Am J Epidemiol, 2008, 168:577-586. [22] Ginde AA, Mansbach JM, Camargo CA.Vitamin D, respiratory infections, and asthma[J].Current Allergy and Asthma Reports, 2009, 9:81-87. [23] Brehm JM, Celedon JC, Soto-Quiros ME, et al.Serum vitamin D levels and markers of severity of childhood asthma in Costa Rica[J].Am J Respir Crit Care Med, 2009, 179:765-771.
PDF(425 KB)
